HbA1c is less reliable in patients with CKD. A study found that glycated albumin associates with important long-term clinical outcomes in a non-dialysis CKD population.
HbA1c is less reliable in patients with CKD. A study found that glycated albumin associates with important long-term clinical outcomes in a non-dialysis CKD population.
Beyond mean hemoglobin A1c, glycemic variability over time may be an additional risk factor for poor kidney outcomes. Long-term glycemic variability may help predict the likelihood of future kidney complications in patients with diabetes.